Clara Estol
Investor at Picus Capital
Clara Estol
Investor at Picus Capital
New York, New York
Overview
Work Experience
Investor
2024 - Current
Venture Fellow
2022 - 2023
Sourced and conducted due diligence on global fintech targets, developed Embedded Finance investment thesis, and pioneered QED's inaugural portfolio playbook to support entrepreneurs.
QED Investors is an investment firm that supports high-growth companies and businesses.
Summer Associate
2022 - 2022
Pre-seed to Series C investment within the Health Tech, Cyber Tech, and Climate Tech sectors.
Emerald Development Managers is a venture capital firm focusing on early-stage growth equity investments.
Chief of Staff ank
2019 - 2021
Developed and implemented strategies for the launch of payment products (P2P, QR, credit card); achieved 1M downloads within five months. I worked with C-level executives on budgeting, annual planning and long-term resource allocation.
Business Analyst
2017 - 2019
Worked in projects in the the Financial Services, Insurance, CPG, Oil&Gas, and Energy sectors. - Led post-acquisition integration of Argentina's largest Oil & Gas company with a leading commodity trading firm, facilitating seamless transfer of assets valued at +$125M - Established and implemented a cost-saving strategy for a global CPG company with 800 full-time employees; resulting in a $60M impact - Executed a commercial transformation for a leading Insurance company attaining a $40M impact. - Designed and implemented an agile transformation for a leading bank including the set-up of new business units (300+ FTEs)
McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity
Co-Founder & CEO
2019 - 2019
Founded IZZY EAT, a PWA streamlining restaurant-customer interaction. The platform enabled real-time order placement and payment through a QR code scan; 5 main Argentinean restaurant chains with +500 restaurants signed up for the pilot and the MVP was tested in 2 of them.
Project Lead
2015 - 2015
Developed a Business Plan for a clinical research to be carried out for Ashkenazi women in Argentina (One in 40 Ashkenazi Jewish women has a BRCA gene mutation. Mutations in BRCA genes raise a person's risk for getting breast cancer and/or ovarian cancer).